1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Active rehabilitation intervention following acute mild traumatic brain injury: A systematic review. (February 2022) Authors: Coman, B.; Powell, D.; Harrison, M.; Rae, G.; Godfrey, A.; Stuart, S. Journal: Physiotherapy Issue: Volume 114(2022)Supplement 1 Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC). Issue 9 (September 2018) Authors: Glynne-Jones, R.; Hall, M.R.; Lopes, A.; Pearce, S.; Goh, V.; Bosompem, S.; Bridgewater, J.; Chau, I.; Wasan, H.; Moran, B.; Melcher, L.; West, N.P.; Quirke, P.; Wong, W.-L.; Beare, S.; Hava, N.; Duggan, M.; Harrison, M. Journal: Heliyon Issue: Volume 4:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. Issue 1 (December 2015) Authors: Glynne-Jones, R.; Hava, N.; Goh, V.; Bosompem, S.; Bridgewater, J.; Chau, I.; Gaya, A.; Wasan, H.; Moran, B.; Melcher, L.; MacDonald, A.; Osborne, M.; Beare, S.; Jitlal, M.; Lopes, A.; Hall, M.; West, N.; Quirke, P.; Wong, Wai-Lup; Harrison, M. Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Compact X-Band electron linac for radiotherapy and security applications. (August 2021) Authors: Kutsaev, S.V.; Agustsson, R.; Arodzero, A.; Berry, R.; Bezhanov, A.; Boucher, S.; Chimalpopoca, O.; Diego, A.; Faillace, L.; Gavryushkin, D.; Harrison, M.; Hartzell, J.J.; McNevin, J.; Ruelas, M.; Smirnov, A. Yu; Verma, A.; Woods, K. Journal: Radiation physics and chemistry Issue: Volume 185(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Crosstalk between CD248 and PDGFR? Regulates the pathogenic role of smooth muscle cells in atherosclerosis. Issue 1 (July 2015) Authors: Harrison, M.; Naylor, A.J.; Apta, B.; Monaco, C.; Buckley, C.D.; Rainger, G.E. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Crosstalk between CD248 and PDGFR? Regulates the pathogenic role of smooth muscle cells in atherosclerosis. Issue 1 (July 2015) Authors: Harrison, M.; Naylor, A.J.; Apta, B.; Monaco, C.; Buckley, C.D.; Rainger, G.E. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Delivering a first contact practitioner service in East London during a global pandemic. (February 2022) Authors: Harrison, M.; Tanner, M. Journal: Physiotherapy Issue: Volume 114(2022)Supplement 1 Page Start: e131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development of an RNA loaded dendritic cell (DC) immunotherapy starting from tissue obtained via needle biopsy. (December 2016) Authors: Tcherepanova, I.; Harris, J.; Spivey, A.; Linville, G.; Rasmussen, J.; Muhitch, J.; Nicolette, C.; Harrison, M.; Schwaab, T. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗